Skip to content

Efficacy of patoladi yogam in Type2 Diabetes mellitus

Efficacy of patoladi yogam as add on medication in Type2 Diabetes mellitus subjects on metformin monotherapy-A randomized placebo controlled trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/040768
Enrollment
50
Registered
2022-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Madonna Valentina Philipose
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.FBS level from 126mg/dl-180mg/dl or PPBS level from 200mg/dl-250mg/dl 2.HbA1C level from 6.5%-8.5% 3.Taking single first line oral hypoglycemic agent metformin

Exclusion criteria

Exclusion criteria: 1.Subjects with the history of severe cardiac, pulmonary,hepatic disorders or neoplasm 2.Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
Fasting blood sugar Post prandial blood sugar HbA1cTimepoint: 0th,31st,61st and 91st day-FBS,PPBS 0th and 91st day-HbA1c

Secondary

MeasureTime frame
Sweating Thirst FatigueTimepoint: 0th day and 91st day

Countries

India

Contacts

Public ContactDr Deepa MS

Government Ayurveda College Thiruvananthapuram

madonnaphilipose90@gmail.com7356825100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026